{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:12:27Z","timestamp":1760933547245,"version":"build-2065373602"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.pmr.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T04:38:23Z","timestamp":1335242303000},"page":"271-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication Safety in Rehabilitation Medicine"],"prefix":"10.1016","volume":"23","author":[{"given":"Laurentiu Iulius","family":"Dinescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"Todorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Biglow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliana","family":"Toderika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karishma","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2012.02.005_bib1","unstructured":"Reducing and preventing adverse drug events to decrease hospital costs. Available at: http:\/\/www.ahrq.gov\/qual\/aderia\/aderia.htm. Accessed December 15, 2011."},{"key":"10.1016\/j.pmr.2012.02.005_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann Intern Med"},{"year":"2004","series-title":"World Alliance for Patient Safety Forward Programme 2005","key":"10.1016\/j.pmr.2012.02.005_bib3"},{"year":"1999","series-title":"To err is human: building a safer health system","author":"Institute of Medicine","key":"10.1016\/j.pmr.2012.02.005_bib4"},{"key":"10.1016\/j.pmr.2012.02.005_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1995.03530010049034","article-title":"Systems analysis of adverse drug events","volume":"274","author":"Leape","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.pmr.2012.02.005_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-147-11-200712040-00006","article-title":"Medication use leading to emergency department visits for adverse drug events in older adults","volume":"125","author":"Budnitz","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archinte.165.4.424","article-title":"Unintended medication discrepancies at the time of hospital admission","volume":"165","author":"Cornish","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib8","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Medication reconciliation. Available at: http:\/\/psnet.ahrq.gov\/primer.aspx?primerID=1. Accessed December 15, 2011."},{"key":"10.1016\/j.pmr.2012.02.005_bib9","first-page":"22","article-title":"The case for medication reconciliation\u2014adapted from the Institute for Healthcare Improvement's Getting Started kit: prevent adverse drug events (medication reconciliation) how-to-guide","year":"2005","journal-title":"Nurs Manage"},{"issue":"5","key":"10.1016\/j.pmr.2012.02.005_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.166.5.565","article-title":"Role of pharmacist counseling in preventing adverse drug events after hospitalization","volume":"166","author":"Schnipper","year":"2006","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.pmr.2012.02.005_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinternmed.2009.51","article-title":"Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial","volume":"169","author":"Schnipper","year":"2009","journal-title":"Arch Intern Med"},{"year":"2003","series-title":"Adherence to long-term therapies: evidence for action","key":"10.1016\/j.pmr.2012.02.005_bib12"},{"key":"10.1016\/j.pmr.2012.02.005_bib13","unstructured":"National Council of Health Information and Education. Enhancing prescription medicine adherence. Rockville (MD): 2007."},{"year":"1997","series-title":"From compliance to concordance: achieving shared goals in medicine taking","author":"Marinker","key":"10.1016\/j.pmr.2012.02.005_bib14"},{"issue":"3","key":"10.1016\/j.pmr.2012.02.005_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ahj.2006.02.030","article-title":"National evaluation of adherence to [beta] blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance","volume":"152","author":"Kramer","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.pmr.2012.02.005_bib16","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2337\/diacare.21.9.1432","article-title":"Population-based assessment of the level of care among adults with diabetes in the U.S","volume":"21","author":"Beckles","year":"1998","journal-title":"Diabetes Care"},{"year":"2000","series-title":"To err is human; building a safer health system","key":"10.1016\/j.pmr.2012.02.005_bib17"},{"key":"10.1016\/j.pmr.2012.02.005_bib18","first-page":"204","article-title":"Medication noncompliance: an issue to consider in the drug selection process","volume":"29","author":"Feldman","year":"1994","journal-title":"Hosp Formul"},{"year":"2003","series-title":"Medication compliance-adherence-persistence digest","key":"10.1016\/j.pmr.2012.02.005_bib19"},{"key":"10.1016\/j.pmr.2012.02.005_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archinte.161.5.706","article-title":"How much information about adverse effects of medication do patients want from physicians?","volume":"161","author":"Ziegler","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib21","series-title":"Patient compliance in medical practice and clinical trials","first-page":"3","article-title":"Overview of methods to measure and enhance patient compliance","author":"Cramer","year":"1991"},{"issue":"6","key":"10.1016\/j.pmr.2012.02.005_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1331\/154434503322642598","article-title":"Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative","volume":"43","author":"Krueger","year":"2003","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.pmr.2012.02.005_bib23","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed?","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.pmr.2012.02.005_bib24","unstructured":"Guidance for medication assessment in patients with swallowing (dysphagia) or feeding disorders. Pharmacy Benefits Management-Strategic Healthcare Group (PBM), June 2006. Available at: http:\/\/www.pbm.va.gov. Accessed December 21, 2011."},{"key":"10.1016\/j.pmr.2012.02.005_bib25","unstructured":"AGS\/BGS Clinical practice guideline: prevention of falls in older persons (2010). American Geriatrics Society. Available at: http:\/\/www.americangeriatrics.org\/health_care_professionals\/clinical_practice\/clinical_guidelines_recommendations\/2010\/. Accessed December 21, 2011."},{"issue":"6","key":"10.1016\/j.pmr.2012.02.005_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF03088515","volume":"40","author":"Deeg","year":"2009","journal-title":"Tijdschr Gerontol Geriatr"},{"issue":"4","key":"10.1016\/j.pmr.2012.02.005_bib27","doi-asserted-by":"crossref","first-page":"M112","DOI":"10.1093\/geronj\/44.4.M112","article-title":"Risk factors for falls in a community-based prospective study of people 70 years of age and older","volume":"44","author":"Campbell","year":"1989","journal-title":"J\u00a0Gerontol"},{"key":"10.1016\/j.pmr.2012.02.005_bib28","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/jama.1987.03390110068028","article-title":"Falls on fractures in patients with Alzheimer's-type dementia","volume":"257","author":"Buchner","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.pmr.2012.02.005_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis, Part I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.pmr.2012.02.005_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis, Part II. Cardiac and analgesic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"21","key":"10.1016\/j.pmr.2012.02.005_bib31","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.pmr.2012.02.005_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CRD.0b013e31815c8032","article-title":"Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope","volume":"16","author":"Medow","year":"2008","journal-title":"Cardiol Rev"},{"issue":"11","key":"10.1016\/j.pmr.2012.02.005_bib33","first-page":"724","article-title":"Medications and falls in the elderly: a review of the evidence and practical considerations","volume":"28","author":"Riefkohl","year":"2003","journal-title":"P T"},{"issue":"6","key":"10.1016\/j.pmr.2012.02.005_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ageing\/afl075","article-title":"Clinical medication review by a pharmacist of elderly people living in care homes- randomized controlled trial","volume":"35","author":"Zermansky","year":"2006","journal-title":"Age Ageing"},{"issue":"10","key":"10.1016\/j.pmr.2012.02.005_bib35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ajhp\/60.10.1029","article-title":"Clinical and economic outcomes of a fall-focused pharmaceutical intervention program","volume":"60","author":"Haumschild","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.pmr.2012.02.005_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0897190007304657","article-title":"Changes in pharmacokinetics and pharmacodynamics in the elderly patient","volume":"20","author":"Hutchison","year":"2007","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.pmr.2012.02.005_bib37","series-title":"Fundamentals of geriatric pharmacotherapy","first-page":"53","article-title":"Biomedical principles of aging","author":"Hutchinson","year":"2010"},{"key":"10.1016\/j.pmr.2012.02.005_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4140\/TCP.n.2008.324","article-title":"Pharmacokinetic and pharmacodynamic alterations in the geriatric patient","volume":"23","author":"Delafuente","year":"2008","journal-title":"Consult Pharm"},{"key":"10.1016\/j.pmr.2012.02.005_bib39","series-title":"Pharmacotherapy: a pathophysiologic approach","first-page":"57","article-title":"Geriatrics","author":"Starner","year":"2008"},{"key":"10.1016\/j.pmr.2012.02.005_bib40","unstructured":"Woosley RL. Drugs that prolong the QT interval and\/or induce torsades de pointes. Arizona Center for Education and Research for Therapeutics. Available at: http:\/\/www.azcert.org\/medical-pros\/drug-lists\/printable-drug-list.cfm. Accessed December 29, 2011."},{"key":"10.1016\/j.pmr.2012.02.005_bib41","series-title":"Drug-induced diseases","first-page":"111","article-title":"Seizures","author":"Quaranta","year":"2005"},{"key":"10.1016\/j.pmr.2012.02.005_bib42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/hcm088","article-title":"Detecting drug interactions using personal digital assistants in an out-patient clinic","volume":"100","author":"Dallenbach","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.pmr.2012.02.005_bib43","unstructured":"Larson AM, Kaplan MM. Drugs and the liver: metabolism and mechanisms of injury. February 3, 2011, Uptodate Web site. Available at: http:\/\/www.uptodate.com\/contents\/drugs-and-the-liver-metabolism-and-mechanisms-of-injury. Accessed December 28, 2011."},{"year":"2007","series-title":"Drug interactions: cytochrome P450 drug interaction table","author":"Flockhart","key":"10.1016\/j.pmr.2012.02.005_bib44"},{"key":"10.1016\/j.pmr.2012.02.005_bib45","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pmr.2012.02.005_bib46","unstructured":"Lexi-Comp Web site. Available at: http:\/\/online.lexi.com\/crlsql\/servlet\/crlonline. Accessed December 29, 2011."},{"key":"10.1016\/j.pmr.2012.02.005_bib47","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1378\/chest.08-0693","article-title":"Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"year":"2005","series-title":"LOVENOX(\u00ae) injection, enoxaparin sodium injection","key":"10.1016\/j.pmr.2012.02.005_bib48"},{"year":"2009","series-title":"FRAGMIN(\u00ae) subcutaneous injection, dalteparin sodium subcutaneous injection","key":"10.1016\/j.pmr.2012.02.005_bib49"},{"year":"2008","series-title":"ARIXTRA (\u00ae) subcutaneous injection, fondaparinux sodium subcutaneous injection","key":"10.1016\/j.pmr.2012.02.005_bib50"},{"key":"10.1016\/j.pmr.2012.02.005_bib51","unstructured":"Product information: PRADAXA (\u00ae) oral capsules, dabigatran etexilate mesylate oral capsules, Boehringer Ingelheim Pharmaceuticals. (per FDA), Ridgefield (CT), 2011."},{"year":"2011","series-title":"XARELTO(\u00ae) oral tablets, rivaroxaban oral tablets","key":"10.1016\/j.pmr.2012.02.005_bib52"},{"issue":"3","key":"10.1016\/j.pmr.2012.02.005_bib53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.semvascsurg.2005.05.006","article-title":"Ambulation and compression after deep vein thrombosis: dispelling myths","volume":"18","author":"Partsch","year":"2005","journal-title":"Semin Vasc Surg"},{"issue":"5","key":"10.1016\/j.pmr.2012.02.005_bib54","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1378\/chest.127.5.1631","article-title":"Bed rest or ambulation in the initial treatment of patients with acute deep vein thrombosis or pulmonary embolism: findings from the Riete registry","volume":"127","author":"Trujillo-Santos","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pmr.2012.02.005_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","article-title":"Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial","volume":"141","author":"Prandoni","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib56","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0003-9993(23)00015-1","article-title":"Etiology, incidence, and prevention of deep vein thrombosis in acute spinal cord injury","volume":"74","author":"Merli","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2012.02.005_bib57","first-page":"661","article-title":"Deep vein thrombosis: prophylaxis in acute spinal cord injured patients","volume":"69","author":"Merli","year":"1988","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2012.02.005_bib58","first-page":"2","article-title":"The validity and reliability of pain measures in adults with cancer","volume":"4","author":"Jensen","year":"2003","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.pmr.2012.02.005_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3959(87)90065-0","article-title":"Sensory-affective relationships among different types of clinical and experimental pain","volume":"28","author":"Price","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2012.02.005_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2012.02.005_bib61","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1160\/TH07-09-0540","article-title":"Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin","volume":"99","author":"Paciaroni","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pmr.2012.02.005_bib62","first-page":"1111","article-title":"Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin","volume":"54","author":"Spinal Cord Injury Thromboprophylaxis Investigators","year":"2003","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.pmr.2012.02.005_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.apmr.2008.09.557","article-title":"Venous thromboembolism after spinal cord injury","volume":"90","author":"Teasell","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2012.02.005_bib64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/10790268.2004.11753754","article-title":"Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury","volume":"27","author":"Hebbeler","year":"2004","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10790268.1997.11719479","article-title":"Prevention of thromboembolism in spinal cord injury. Consortium for Spinal Cord Medicine","volume":"20","year":"1997","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3959(94)90097-3","article-title":"A\u00a0comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales","volume":"56","author":"Price","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2012.02.005_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/10790268.2003.11753701","article-title":"Diagnosis: prevalence, and management of thromboembolism in patients with spinal cord injury","volume":"26","author":"Green","year":"2003","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2012.02.005_bib69","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/jama.1986.03380060070028","article-title":"Consensus Conference: prevention of venous thrombosis and pulmonary embolism","volume":"256","author":"Office of Medical Applications of Research National Institutes of Health","year":"1986","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.pmr.2012.02.005_bib70","first-page":"S379","article-title":"Venous thromboembolism in stroke: literature review and implications for clinical practice","volume":"73","author":"Brandstater","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2012.02.005_bib71","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0003-9993(96)90145-8","article-title":"Deep venous thrombosis: incidence on admission to a brain injury rehabilitation program","volume":"77","author":"Cifu","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2012.02.005_bib72","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pmr.2012.02.005_bib73","first-page":"142","article-title":"Practice management for the prevention of venous thromboembolism in trauma patients: the EAST Practice Management Guidelines Work Group","volume":"53","author":"Rogers","year":"2002","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.pmr.2012.02.005_bib74","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Heparin-induced thrombocytopenia","volume":"355","author":"Arepally","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib75","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.CCM.0000259538.02375.A5","article-title":"Heparin-induced thrombocytopenia in intensive care patients","volume":"35","author":"Selleng","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib76","series-title":"Pharmacotherapy: a pathophysiologic approach","first-page":"331","article-title":"Venous thromboembolism","author":"Haines","year":"2008"},{"key":"10.1016\/j.pmr.2012.02.005_bib77","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pmr.2012.02.005_bib78","unstructured":"International Association for the Study of Pain (IASP). Available at: http:\/\/www.iasp-pain.org. Accessed December 2011."},{"key":"10.1016\/j.pmr.2012.02.005_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(98)00138-9","article-title":"Assessment and treatment of neuropathic cancer pain following WHO guidelines","volume":"79","author":"Grond","year":"1999","journal-title":"Pain"},{"year":"2002","series-title":"Pain management in rehabilitation","author":"Grabois","key":"10.1016\/j.pmr.2012.02.005_bib80"},{"issue":"12","key":"10.1016\/j.pmr.2012.02.005_bib81","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","article-title":"Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users","volume":"21","author":"Vergara","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pmr.2012.02.005_bib82","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"year":"2009","series-title":"Palliative pharmacy care","author":"Strickland","key":"10.1016\/j.pmr.2012.02.005_bib83"},{"key":"10.1016\/j.pmr.2012.02.005_bib84","unstructured":"Ouellet M, Beaulieu-Bonneau S. Sleep disorders in rehabilitation patients. In: Stone JH, Blouin M, editors. International encyclopedia of rehabilitation. 2012. Available at: http:\/\/cirrie.buffalo.edu\/encyclopedia\/en\/article\/43\/. Accessed December 26, 2011."},{"issue":"Suppl 16","key":"10.1016\/j.pmr.2012.02.005_bib85","first-page":"4","article-title":"The neurotransmitters of sleep","volume":"65","author":"Siegel","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"Suppl 16","key":"10.1016\/j.pmr.2012.02.005_bib86","first-page":"8","article-title":"Characteristics and determinants of normal sleep","volume":"65","author":"Roth","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.pmr.2012.02.005_bib87","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.amjmed.2005.10.051","article-title":"Insomnia in the elderly: cause, approach, and treatment","volume":"119","author":"Kamel","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib88","first-page":"517","article-title":"Treatment options for insomnia","volume":"76","author":"Ramakrishnan","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pmr.2012.02.005_bib89","series-title":"Drug-induced diseases: prevention, detection, and management","first-page":"185","article-title":"Sleep disorders","author":"Larive","year":"2005"},{"key":"10.1016\/j.pmr.2012.02.005_bib90","series-title":"Behavioral medicine: a guide for clinical practice","article-title":"Sleep disorders","author":"Singer","year":"2008"},{"issue":"5","key":"10.1016\/j.pmr.2012.02.005_bib91","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schuttle-Rodin","year":"2008","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00175180","article-title":"Evaluation of l-tryptophan for treatment of insomnia: a review","volume":"89","author":"Schneider-Helmert","year":"1986","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.pmr.2012.02.005_bib93","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"issue":"Suppl 13","key":"10.1016\/j.pmr.2012.02.005_bib94","first-page":"16","article-title":"Narcolepsy: treatment issues","volume":"68","author":"Roth","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.pmr.2012.02.005_bib95","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.0b013e3181fd62a2","article-title":"Modafanil ameliorates excessive daytime sleepiness after traumatic brain injury","volume":"75","author":"Kaiser","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2012.02.005_bib96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM199402103300601","article-title":"Risk factors for gastrointestinal bleeding in critically ill patients","volume":"330","author":"Cook","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2012.02.005_bib97","first-page":"728","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pmr.2012.02.005_bib98","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00535-008-2275-5","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy","volume":"44","author":"Schalansky","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pmr.2012.02.005_bib99","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1528-1157.1987.tb05776.x","article-title":"Anticonvulsant drugs and cognitive function: a review of the literature","volume":"28","author":"Trimble","year":"1987","journal-title":"Epilepsia"},{"year":"2008","series-title":"Stahl's essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl","key":"10.1016\/j.pmr.2012.02.005_bib100"},{"issue":"2","key":"10.1016\/j.pmr.2012.02.005_bib101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","article-title":"The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis","volume":"25","author":"Keefe","year":"1999","journal-title":"Schizophr Bull"},{"issue":"10","key":"10.1016\/j.pmr.2012.02.005_bib102","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002018-200629100-00004","article-title":"Neuropsychiatric complications of antiretroviral therapy","volume":"29","author":"Cespedes","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.pmr.2012.02.005_bib103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1192\/apt.11.1.58","article-title":"Psychiatric side-effects of medications: recent developments","volume":"11","author":"Turjanski","year":"2005","journal-title":"Adv Psychiatr Treat"},{"issue":"2 Suppl","key":"10.1016\/j.pmr.2012.02.005_bib104","article-title":"Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","year":"2012","journal-title":"Chest"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965112000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965112000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:34:23Z","timestamp":1760931263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965112000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1047965112000137"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2012.02.005","relation":{},"ISSN":["1047-9651"],"issn-type":[{"type":"print","value":"1047-9651"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication Safety in Rehabilitation Medicine","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2012.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}